China Biologic Committee To Weigh $4.59B Take-Private Bid
China Biologic's board of directors has formed a special committee to review a $4.59 billion take-private proposal, the biopharmaceutical company said Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article